Announcements
5 December 2023
Cancers 2023 Young Investigator Award—Winner Announced
30 November 2023
MDPI Insights: The CEO's Letter #6 - MDPI Spain Summit and ResearchGate
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI Spain Summit
Stefan Tochev (CEO, MDPI) gives the opening speech at the MDPI Spain Summit.
On Friday 10 November 2023 I was in Barcelona, Spain, to deliver the opening presentation and participate in a panel at MDPI’s Spain Summit, a two-day event, inspired by our salon events in China.
With 16 Editors-in-Chief (EiCs) and 20 Editorial Board Members (EBMs) in attendance, the event, organized by our conference team and Barcelona office, featured presentations on open access (OA), MDPI, and publishing market trends in Spain.
The event provided a great opportunity to engage with stakeholders from various MDPI journals, including Nutrients, Vaccines, Buildings, IJMS, and others. We were able to gather feedback and have open conversations around manuscript quality, the peer-review process, and journal development, as well as accreditation agencies.
Connecting with Editorial Board Members
Stefan Tochev in conversation with Summit participants: "Our EBMs are passionate about the journals they serve."
Interacting with our EBMs in person provides a valuable opportunity to show how important it is to us to connect with them, hear their perspectives on their journals and learn more about their own experience collaborating with MDPI.
From my conversations, it was clear that our EBMs are passionate about the journals they serve. I know the advice they provide may sometimes involve just small tweaks, but these can lead to important improvements. As the saying goes, small hinges swing open big doors.
As at November 2023, MDPI has over 6,300 EBMs affiliated with Spanish institutions, with more than 30 of them serving as EiCs or section EiCs. Furthermore, over 68,000 Spanish scholars have contributed as reviewers in MDPI journals.
Open Access in Spain
In 2023, Spain implemented legislation mandating immediate OA for all publicly funded research, aligning with the EU’s Plan S initiative to expedite the transition to OA. The Spanish government also approved a four-year, €23.8 million annual budget for the first national OA strategy, aiming to make publicly funded research freely accessible upon publication. This strategy aims to strengthen the quality and transparency of research in Spain, and to help promote movement towards a digital, low-carbon economy.
For further details of Spain's OA policy and the history of government mandates, click here.
Spain has already seen a notable decline in subscription-only articles, decreasing by 62% over a 10-year period, while gold OA increased by 42%. Green OA slightly decreased, suggesting a shift towards publishing in gold OA journals rather than traditional subscription-based ones. Here are some statistics from Scopus.
A big thank-you to the various MDPI teams, including our conference team and the Barcelona office, for organizing this very successful event!
MDPI colleagues from various offices gathered to host and support the first MDPI Spain Summit, in Barcelona, Spain.
I think this type of gathering has the potential to become an annual event in various locations. For example, Manchester could be an option, as we have over 30 EiCs and over 3,000 EBMs in the UK, a top market for MDPI that publishes high-quality research.
Impactful Research
769 Editorial Board Members of MDPI Journals Recognized as Highly Cited Researchers in 2023
Congratulations to our 769 Editorial Board Members from 40 countries/territories who have been awarded Highly Cited Researcher status for 2023 by Clarivate. This recognition is based on their outstanding scientific research contributions and significant influence in various fields, as evidenced by Web of Science data.
Click here to view the full list of 769 Editorial Board Members.
Clarivate's Highly Cited ResearchersTM list identifies individuals with exceptional impact in scientific and social science domains over the past decade. Their papers rank in the top 1% of citations in 21 fields analysed in ‘Essential Science Indicators,’ showcasing their substantial influence.
This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.
These researchers demonstrate exceptional influence, representing a small fraction of contributors pushing the boundaries of knowledge, contributing to global well-being, sustainability, and security.
Congratulations to these scholars for their remarkable achievement: we are honoured to have them on board with our journals!
Inside MDPI
Corporate Marketing and Communications Strategy Session
Members of MDPI’s Corporate Marketing & Communications team.
For the past few years, I have led the Corporate Marketing & Communications department in our annual strategy session.
This typically involves 2–3 days of focused sessions covering key topics including budgeting, hiring targets, campaign reviews, and planning for the upcoming year, department strategy, and structure.
We are constantly exploring ways to optimize the Corporate Marketing & Communications department to support MDPI’s primary objectives and better convey the MDPI story while serving the scholarly community.
The strategy session also serves as a team-building activity, during which the team voted on bowling!
Strategy Session
In this strategy session, we looked at how to align our teams in order to better streamline our content with our campaigns, build a dedicated marketing team to strategically support our core MDPI products, expand our communications teams and functionalities to focus on company-critical campaigns and press releases, align our new brand design system with our marketing initiatives, set up a community and engagement team to support various teams with their outreach and communication efforts, and increase our use of data in the evaluation of campaign performance.
To grow in these areas, we will be hiring for various positions, including those of Public Relations Manager, Communications Manager, Internal Communications Manager, Campaign Manager, Marketing Associate, and Editorial Engagement Manager.
I am grateful for the way our Corporate Marketing & Communications department has grown and gelled over the years, and I look forward to supporting the department teams and their ideas for the future.
Coming Together for Science
ResearchGate and MDPI Partner to Boost the Visibility of Open Access Content through Journal Home
Stefan Tochev (CEO, MDPI) and Sören Hofmayer (Co-Founder and Chief Strategy Officer, ResearchGate) meet in Berlin, Germany to take their ongoing discussion further.
When I assumed the role of CEO at MDPI, my primary focus was to initiate the building of essential partnerships and collaborations within our industry. After all, I am a firm believer in achieving our goals by helping others achieve theirs and focusing on co-opetition wherever there is an opportunity. I first touched on the notion of co-opetition in MDPI Insights: The CEO's Letter #3, particularly when discussing collaborations with Elsevier.
In light of this, Sören Hofmayer (Co-Founder and Chief Strategy Officer at ResearchGate) and I connected recently to continue a discussion that had been ongoing for months. I was quickly brought up to speed and felt there was an opportunity for MDPI journals to pilot the Journal Home service that ResearchGate had launched. This would provide a new way for MDPI to engage with authors and readers and amplify the visibility of our journals.
While I receive many offers and opportunities for discussions with vendors, I am a firm believer that timing is everything, and in this case, the time for us is now. Sören and I met in person during my recent visit to Berlin and decided to proceed with piloting ten MDPI journals with the Journal Home service.
The press release below provides further details.
Press Release: Berlin (Germany) and Basel (Switzerland), 15 November 2023
ResearchGate, the professional network for researchers, and MDPI, the largest open access publisher in the world and a pioneer in open access publishing, today announced a partnership that will see ten of MDPI’s open access journals benefit from an enhanced presence on ResearchGate through its innovative Journal Home offering.
This new partnership will expand the reach and visibility of MDPI’s participating flagship journals with ResearchGate’s highly relevant community of more than 25 million researchers globally.
Around 210,000 version-of-record articles from these 10 titles will be readily available on ResearchGate, including the full archive material and all new articles as they are published. These journals also benefit from enhanced brand visibility, with dedicated journal profiles, prominent representation on all associated article pages and all relevant touchpoints across the ResearchGate network – keeping the journals top-of-mind with their reader and author audiences. All articles covered by the new partnership will automatically be added to the authors’ publication records in ResearchGate. This not only reduces MDPI authors’ needs for direct management but also offers them valuable insights into the impact of their work, including data about readership and citations.
Closing Thoughts
November is Men’s Health Awareness Month
Stefan Tochev (CEO, MDPI) listening to music as he writes at a coffee shop in Basel, Switzerland.
November is dedicated to raising awareness of various men’s health issues. I have been fortunate to have positive male role models in my life, and I strive to share my experiences with others.
I used to take part in Movember, growing my moustache throughout November to raise awareness and funds and to help “change the face of men’s health.” With male family and friends impacted by physical and mental health issues, I have recently become more interested in men’s overall well-being.
Men often face stigma involving the perceived need always to be strong and have things figured out. Recently, I’ve had meaningful conversations with male friends and colleagues about issues we rarely discuss, and it was a positive experience.
Various factors impact men’s health and well-being, all too easily leading to risky health behaviours including a lack of health awareness, poor health education, and negative, culturally induced, behaviour patterns in our work and personal lives. I hope we can break down these barriers in our work environment.
Healthy men help build healthy families and a healthy society
Men are less likely than women to seek help with their physical and mental health struggles. This is a reminder to prioritize your overall well-being. I hope that as men, we will continue to open up to one another, becoming vulnerable in order to share what we are going through. By sharing and by supporting each other, we can learn and grow together. You are not alone, and when you fall, you can still get up and stand tall.
From one broski to another, you are loved and appreciated. I hope this mindset carries into December and beyond.
Mindfulness
Our content team recently released a handful of articles on mindfulness, a practice that I believe provides a good opportunity for stress release and self-reflection:
Chief Executive Officer
MDPI AG
29 November 2023
Cancers | Highly Cited Special Issues on Pediatric Oncology in 2022
We are pleased to invite you to read the highly cited Special Issues on pediatric oncology in 2022. The Special Issues list is as follows:
|
|
Edited by: Dr. Saurabh Agarwal and Dr. Jianhua Yang |
|
|
“Targeted Therapies for Pediatric Solid Tumors” Edited by: Dr. Michele Bernasconi |
|
|
“Recent Advances in Pediatric, Adolescent and Young Adult (AYA) Psycho-Oncology” Edited by: Dr. Ursula Sansom-Daly, Dr. Jordana McLoone, Dr. Christina Signorelli and Dr. Lauren Winkler |
|
|
“Childhood and Adolescent Cancer” Edited by: Dr. Henrike Karim-Kos and Dr. Rob Pieters |
|
|
Edited by: Dr. Irit Ben Aharon and Dr. Savio George Barreto |
|
|
“Frailty in Pediatric and Young Adult Cancer Survivors: From Bench to Bedside” Edited by: Prof. Francesca Rossi |
You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers.
Cancers Editorial Office
28 November 2023
Editorial Board Members from Cancers Featured in the 2023 Highly Cited Researchers List Published by Clarivate
23 November 2023
Cancers | Highly Cited Special Issues on Cancer Pathophysiology in 2022
We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on Cancer Pathophysiology. We hope this announcement will provide useful information for this field.
The Special Issues list is as follows:
|
|
|
|
“Signaling Pathway in Gastrointestinal Cancer” |
“Advances in Oral Cancer: From Pathology to Treatment” |
|
|
|
|
“Update in Lung Cancer Molecular Pathology: Technological Advances and Clinical Practice” |
“Image Analysis and Computational Pathology in Cancer Diagnosis” |
|
|
|
|
“Pathophysiology and Treatment of Gallbladder Cancer” |
“Predictive and Prognostic Markers in Brain Tumors: From Physiopathology to Clinical Applications” |
You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office at cancers@mdpi.com.
Cancers Editorial Office
22 November 2023
Cancers | Lung Cancer Awareness Month
November is designated as “Lung Cancer Awareness Month”, with various global activities that highlight and increase awareness of lung cancer for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of lung cancers, which published in Cancers (ISSN: 2072-6694). We hope this announcement will provide the useful information for this field.
“Upregulation of CD36, a Fatty Acid Translocase, Promotes Colorectal Cancer Metastasis by Increasing MMP28 and Decreasing E-Cadherin Expression”
by James Drury, Piotr G. Rychahou, Courtney O. Kelson, Mariah E. Geisen, Yuanyuan Wu, Daheng He, Chi Wang, Eun Y. Lee, B. Mark Evers and Yekaterina Y. Zaytseva
Cancers 2022, 14(1), 252; https://doi.org/10.3390/cancers14010252
Available online: https://www.mdpi.com/2072-6694/14/1/252
“Metastatic Progression of Osteosarcomas: A Review of Current Knowledge of Environmental versus Oncogenic Drivers”
by Guillaume Anthony Odri, Joëlle Tchicaya-Bouanga, Diane Ji Yun Yoon and Dominique Modrowski
Cancers 2022, 14(2), 360; https://doi.org/10.3390/cancers14020360
Available online: https://www.mdpi.com/2072-6694/14/2/360
“Inflammation, Fibrosis and Cancer: Mechanisms, Therapeutic Options and Challenges”
by Bocheng Wu, Quaovi H. Sodji and Adegboyega K. Oyelere
Cancers 2022, 14(3), 552; https://doi.org/10.3390/cancers14030552
Available online: https://www.mdpi.com/2072-6694/14/3/552
“Exosomal Proteins and Lipids as Potential Biomarkers for Lung Cancer Diagnosis, Prognosis, and Treatment”
by Ming-Tsung Hsu, Yu-Ke Wang and Yufeng Jane Tseng
Cancers 2022, 14(3), 732; https://doi.org/10.3390/cancers14030732
Available online: https://www.mdpi.com/2072-6694/14/3/732
“Systematic Review of Single-Fraction Stereotactic Body Radiation Therapy for Early Stage Non-Small-Cell Lung Cancer and Lung Oligometastases: How to Stop Worrying and Love One and Done”
by Austin J. Bartl, Mary Mahoney, Mark W. Hennon, Sai Yendamuri, Gregory M. M. Videtic, Kevin L. Stephans, Shankar Siva, Mark K. Farrugia, Sung Jun Ma and Anurag K. Singh
Cancers 2022, 14(3), 790; https://doi.org/10.3390/cancers14030790
Available online: https://www.mdpi.com/2072-6694/14/3/790
“Cannabidiol Inhibits Tumorigenesis in Cisplatin-Resistant Non-Small Cell Lung Cancer via TRPV2”
by Swati Misri, Kirti Kaul, Sanjay Mishra, Manish Charan, Ajeet Kumar Verma, Martin P. Barr, Dinesh K. Ahirwar and Ramesh K. Ganju
Cancers 2022, 14(5), 1181; https://doi.org/10.3390/cancers14051181
Available online: https://www.mdpi.com/2072-6694/14/5/1181
“Direct Targeting KRAS Mutation in Non-Small Cell Lung Cancer: Focus on Resistance”
by Damien Reita, Lucile Pabst, Erwan Pencreach, Eric Guérin, Laurent Dano, Valérie Rimelen, Anne-Claire Voegeli, Laurent Vallat, Céline Mascaux and Michèle Beau-Faller
Cancers 2022, 14(5), 1321; https://doi.org/10.3390/cancers14051321
Available online: https://www.mdpi.com/2072-6694/14/5/1321
“Application of Artificial Intelligence in Lung Cancer”
by Hwa-Yen Chiu, Heng-Sheng Chao and Yuh-Min Chen
Cancers 2022, 14(6), 1370; https://doi.org/10.3390/cancers14061370
Available online: https://www.mdpi.com/2072-6694/14/6/1370
“Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis”
by Alessandro Rizzo, Antonio Cusmai, Francesco Giovannelli, Silvana Acquafredda, Lucia Rinaldi, Andrea Misino, Elisabetta Sara Montagna, Valentina Ungaro, Mariagrazia Lorusso and Gennaro Palmiotti
Cancers 2022, 14(6), 1404; https://doi.org/10.3390/cancers14061404
Available online: https://www.mdpi.com/2072-6694/14/6/1404
“Lung Adenocarcinoma Tumor Origin: A Guide for Personalized Medicine”
by Laetitia Seguin, Manon Durandy and Chloe C. Feral
Cancers 2022, 14(7), 1759; https://doi.org/10.3390/cancers14071759
Available online: https://www.mdpi.com/2072-6694/14/7/1759
|
“Prevention and Quality of Life of Lung Cancer” Edited by: Prof. Dr. Servet Bölükbas
|
“Mechanisms of Therapy Resistance in Lung Cancer” Edited by: Dr. Andrea De Giglio |
|
“Novel Biomarkers in Non-small Cell Lung Cancer (NSCLC)” Edited by: Dr. Alfredo Tartarone
|
“Genetic, Epigenetic, and Epitranscriptomic Changes in Lung Cancer” Edited by: Dr. Giovanni Nigita, Dr. Mario Acunzo and Dr. Patrick Nana-Sinkam
|
You are welcome to submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.
Cancers Editorial Office
21 November 2023
769 Editorial Board Members of MDPI Journals Achieve Highly Cited Researcher Recognition in 2023
21 November 2023
Cancers | Top 10 Cited Papers in 2021 in the Section “Cancer Drug Development”
17 November 2023
Cancers | Highly Cited Special Issues on Cancer Epidemiology and Prevention in 2022
We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on cancer epidemiology and prevention. We hope this announcement will provide useful information for this field.
The Special Issues list is as follows:
You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. You can contact the Editorial Office at cancers@mdpi.com.
Cancers Editorial Office
16 November 2023
Cancers | Highly Cited Special Issues on Tumor Microenvironment in 2022
We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on tumor microenvironment. We hope this announcement will provide useful information for this field.
The Special Issues list is as follows:
 “Molecular Aspects of Tumor Microenvironment of Colorectal Cancers”Edited by Prof. Dr. Maria Cristina Curia Viewed by 17900+ | Cited by 70+ |
 “Engineering the Tumor Immune Microenvironment”Edited by Dr. Scott S. Verbridge Viewed by 35900+ | Cited by 60+ |
 “Primary Bone Tumors: Microenvironment, Signaling and Therapeutic Targeting”Edited by Dr. Françoise Rédini and Dr. Franck Verrecchia Viewed by 14900+ | Cited by 30+ |
 “Inflammation and the Immunosuppressive Pancreatic Cancer Microenvironment“Edited by Dr. Brian A. Boone and Dr. Tim D. Eubank Viewed by 19500+ | Cited by 90+ |
 “Multicellular Effects of STAT3 in the Tumour Microenvironment”Edited by Dr. Ashwini L. Chand Viewed by 19200+ | Cited by 70+ |
 “Cancer Microenvironment–Hypoxia“Edited by Dr. María Dolores Chiara Romero Viewed by 15900+ | Cited by 40+ |
You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers via cancers@mdpi.com.
Cancers Editorial Office
